| Primitive Neuroectodermal Tumor studied in …STUDIED_INderived200 of 673show all (up to 200) |
|---|
| → studied in | NCT04724369Phase 3 · completed Open-Label Study of 18F-mFBG for Imaging Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06479811Phase 1 · recruiting [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers · condition mapped ALIAS · 673 trials mapped (177 active) | — | — | Olfactory Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01109394recruiting Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01445288completed Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors · condition mapped ALIAS · 673 trials mapped (177 active) | — | — | Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06441331Phase 1 · recruiting Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06172296Phase 3 · recruiting Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Ganglioneuroblastoma, Nodular | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06995872Phase 1 · recruiting Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04837547Phase 1 · active not recruiting PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01005654recruiting Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01857934Phase 2 · completed Therapy for Children With Advanced Stage Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03210714Phase 2 · active not recruiting Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03251989completed Rare CNS Tumors Outcomes &Risk · condition mapped ALIAS · 673 trials mapped (177 active) | — | — | Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06814496Phase 1/Phase 2 · recruiting Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors · condition mapped ALIAS · 673 trials mapped (177 active) | — | — | Olfactory Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07833631completed A Prospective Image Reevaluation Study to Assess the Efficacy of 18F-mFBG PET Imaging in Subjects With Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03698994Phase 2 · active not recruiting Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06176989Phase 2 · recruiting Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors · condition mapped CURATED_BROADER · 673 trials mapped (177 active) | — | — | Olfactory Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05421897Phase 2 · active not recruiting Rapid Administration Pilot for Infusing Dinutuximab · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06395103Phase 1/Phase 2 · recruiting Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01) · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07537400Phase 2 · recruiting Patients Between the Ages of 12 Months to 21 Years With Newly-Diagnosed High-Risk Neuroblastoma Will Receive Children's Oncology Group (COG) Type Recommended Therapy With the Addition of Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) to Induction Cycles 1-5 · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | High Risk Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04211675Phase 1/Phase 2 · active not recruiting NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab · condition mapped CURATED_BROADER · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06858501Phase 2 · withdrawn Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Ganglioneuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07819838Phase 1/Phase 2 · not yet recruiting Testing the Addition of an Anti-Cancer Drug, Daraxonrasib, for Relapsed or Refractory Solid Tumors With RAS Mutations · condition mapped CURATED_BROADER · 673 trials mapped (177 active) | — | — | Childhood Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06674811recruiting Biomarkers of Resiliency In Childhood Cancer Surgery · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05027386Phase 1/Phase 2 · completed Apatinib Mesylate Combined With IT Regimen for the Treatment of Recurrent or Refractory Neuroblastoma: A Single-arm, Phase I/II，Multi-center, Clinical Study. · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07437963Phase 1/Phase 2 · not yet recruiting Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse · condition mapped CURATED_BROADER · 673 trials mapped (177 active) | — | — | Ganglioneuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01711554Phase 1 · active not recruiting Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma · condition mapped CURATED_BROADER · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02559778Phase 2 · recruiting Pediatric Precision Laboratory Advanced Neuroblastoma Therapy · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03911388Phase 1 · recruiting HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors · condition mapped ALIAS · 673 trials mapped (177 active) | — | — | Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02679144Phase 2 · active not recruiting Neuroblastoma Maintenance Therapy Trial · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04301843Phase 2 · active not recruiting Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06465199Phase 1/Phase 2 · recruiting Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06540963Phase 2 · recruiting Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06541262Phase 1/Phase 2 · recruiting Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07358260Phase 1 · recruiting B7-H3.CD28Z.CART in Solid Tumors · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01875601Phase 1 · completed NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04637503Phase 1/Phase 2 · not yet recruiting 4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06528496Phase 2 · recruiting N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | High Risk Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02176967Phase 3 · active not recruiting Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Ganglioneuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03126916Phase 3 · recruiting Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL) · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Ganglioneuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04851119Phase 1/Phase 2 · recruiting Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07635056Phase 2 · recruiting Haploidentical Donor Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04106219Phase 1 · active not recruiting A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05701306Phase 1/Phase 2 · recruiting APG-115 Alone or in Combination With APG-2575 in Recurrent or Refractory Neuroblastoma or Solid Tumors · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07261241Phase 2 · not yet recruiting NANT 2021-02: Randomized MIBG With Vorinostat/Dinutuximab/Vorinostat + Dinutuximab · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07767630early Phase 1 · recruiting Safety, Tolerability, and Preliminary Efficacy of [211At]MABG in Patients With Relapsed or Refractory Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02112617NA · active not recruiting Phase II Study of Proton Radiation Therapy for Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02282735active not recruiting Parental Decision-Making for Children With Relapsed Neuroblastoma · condition mapped CURATED_BROADER · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00918320Phase 2 · completed Studies of Temozolomide in Combination With Topotecan in Refractory and Relapsed Paediatric Solid Tumours · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00407433Phase 2 · completed Clinical Studies of Gemcitabine-Oxaliplatin · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04755205recruiting A Natural History Study of Children and Adults With Olfactory Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Olfactory Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05650749Phase 1 · enrolling by invitation GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma and Metastatic Retinoblastoma · condition mapped CURATED_BROADER · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01326104Phase 2 · completed Vaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor · condition mapped ALIAS · 673 trials mapped (177 active) | — | — | Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07136701recruiting Risk Factors, Prognosis, Clinicopathological and Metabolic Characteristics of EO- vs LO-PanNETs · condition mapped ALIAS · 673 trials mapped (177 active) | — | — | Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07172958Phase 1 · recruiting Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE) · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05489887Phase 2 · recruiting Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07527169Phase 2 · not yet recruiting A Phase 2 Study Of Zanzalintinib For Patients With Recurrent Or Metastatic Olfactory Neuroblastoma · condition mapped CURATED_BROADER · 673 trials mapped (177 active) | — | — | Olfactory Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04936529Phase 2 · recruiting A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05642455Phase 1/Phase 2 · recruiting SPEARHEAD-3 Pediatric Study · condition mapped ALIAS · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04947501early Phase 1 · active not recruiting A Study of N9 Chemotherapy in Children With Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03015844available A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00911560Phase 1/Phase 2 · completed Bivalent Vaccine With Escalating Doses of the Immunological Adjuvant OPT-821, in Combination With Oral β-glucan for High-Risk Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04539366Phase 1 · suspended Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, GD2-CAR PERSIST Trial · condition mapped CURATED_BROADER · 673 trials mapped (177 active) | — | — | Childhood Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06822842completed Accurate Diagnosis and Grading of Pediatric Solid Tumors Based on Pathological Large Models · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04320888Phase 2 · active not recruiting Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial · condition mapped CURATED_BROADER · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03363373Phase 2 · active not recruiting Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04337177Phase 1 · active not recruiting Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02306161Phase 3 · active not recruiting Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma · condition mapped CURATED_BROADER · 673 trials mapped (177 active) | — | — | Peripheral Primitive Neuroectodermal Tumor of Bone | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06057948Phase 2 · recruiting A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03155620Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) · condition mapped CURATED_BROADER · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05592743approved for marketing Vorasidenib Expanded Access Program · condition mapped ALIAS · 673 trials mapped (177 active) | — | — | Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01370330available 131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06721689Phase 1/Phase 2 · recruiting PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors · condition mapped CURATED_BROADER · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07211737Phase 1 · recruiting NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma · condition mapped CURATED_BROADER · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06450041Phase 2 · recruiting NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04284774Phase 2 · active not recruiting Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial · condition mapped CURATED_BROADER · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06942039early Phase 1 · recruiting Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07027748Phase 1 · recruiting Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213652Phase 2 · active not recruiting Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00904241completed Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Ganglioneuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07688252Phase 1 · not yet recruiting Dinutuximab-beta and Chemotherapy in Newly Diagnosed High-Risk Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | High Risk Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03189706early Phase 1 · active not recruiting Study of Chemoimmunotherapy for High-Risk Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03635632Phase 1 · active not recruiting C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N) · condition mapped CURATED_BROADER · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04195555Phase 2 · active not recruiting Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07007117Phase 1 · active not recruiting PHOX2B PC-CAR T Cells for Relapsed Neuroblastoma · condition mapped CURATED_BROADER · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04751383Phase 1 · terminated Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | High Risk Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06625190Phase 1/Phase 2 · recruiting Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05130255Phase 1 · terminated GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2 · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | High Risk Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00840047Phase 2 · active not recruiting Methionine PET/CT Studies In Patients With Cancer · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03050268recruiting Familial Investigations of Childhood Cancer Predisposition · condition mapped ALIAS · 673 trials mapped (177 active) | — | — | Hereditary Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213704Phase 2 · active not recruiting Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03541720early Phase 1 · active not recruiting 18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06104488Phase 1 · active not recruiting A Study of Avutometinib for People With Solid Tumor Cancers · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01192555Phase 1/Phase 2 · active not recruiting Allogeneic Tumor Cell Vaccination With Oral Metronomic Cytoxan in Patients With High-Risk Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04500548Phase 1 · withdrawn Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI Study · condition mapped CURATED_BROADER · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06607692Phase 1/Phase 2 · recruiting Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | High Risk Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07318831Phase 2 · recruiting Phase II Study of Chidamide-Dinutuximab Beta-Irinotecan-Temozolomide for Refractory/Relapsed Neuroblastoma in Children · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03786783Phase 2 · completed Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Ganglioneuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00107289Phase 2 · recruiting Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04559217Phase 2 · recruiting 68Ga-DOTATATE Neuroblastoma Imaging Pilot · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04087902active not recruiting Long-Term Longitudinal QoL in Patients Undergoing EEA · condition mapped ALIAS · 673 trials mapped (177 active) | — | — | Olfactory Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02311621Phase 1 · active not recruiting Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01 · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04897321Phase 1 · recruiting B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04901702Phase 1/Phase 2 · recruiting Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma · condition mapped CURATED_BROADER · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07595666NA · enrolling by invitation Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region. · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07584499Phase 1 · recruiting Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02308527Phase 2 · completed Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03583528active not recruiting DOTATOC PET/CT for Imaging NET Patients · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06500819Phase 1 · recruiting Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06068075NA · active not recruiting Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03966651Phase 1 · completed A Clinical Study Evaluating the Safety of Peptide Receptor Radionuclide Therapy (PRRT) With 177Lu-DOTA0-Tyr3-Octreotate in Children With Refractory or Recurrent Neuroblastoma Expressing Somatostatin Receptors. · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00253435Phase 2 · completed N2001-02: I-MIBG With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02914405Phase 1 · active not recruiting Phase I Study of 131-I mIBG Followed by Nivolumab & Dinutuximab Beta Antibodies in Children With Relapsed/Refractory Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04483778Phase 1 · active not recruiting B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05990751Phase 1 · active not recruiting Multi-modular Chimeric Antigen Receptor Targeting GD2 in Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07549425active not recruiting Construction and Validation of an Intelligent Ultrasound Diagnostic System for the Spectrum of Neuroblastoma in Children · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastic Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01953900Phase 1 · active not recruiting iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213678Phase 2 · completed Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04308330Phase 1 · recruiting Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06638931Phase 2 · recruiting Agnostic Therapy in Rare Solid Tumors · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00083135Phase 1 · completed N2000-01: Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093353Phase 1 · completed N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00295919Phase 1 · completed N2004-04: Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00509353Phase 1 · completed N2004-06: Irinotecan and Vincristine With 131I-MIBG Therapy for Resistant/Relapsed High-Risk Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00646230Phase 1 · completed N2004-03: Intravenous Fenretinide in Treating Young Patients With Recurrent or Resistant Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01163383available 131-I-MIBG Therapy for Refractory Neuroblastoma, Expanded Access Protocol · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213665Phase 2 · completed Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04185038Phase 1 · recruiting Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07516678recruiting Serial ctDNA and Molecular Residual Disease Monitoring in Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07518654Phase 1 · not yet recruiting Phase I Clinical Trial of ThINKK Adoptive Immunotherapy After Allogeneic Hematopoietic Transplantation in Children With Leukemia or Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01822652Phase 1 · active not recruiting 3rd Generation GD-2 Chimeric Antigen Receptor and iCaspase Suicide Safety Switch, Neuroblastoma, GRAIN · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03526250Phase 2 · completed Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04040088early Phase 1 · active not recruiting An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Ganglioneuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07502287Phase 1/Phase 2 · recruiting Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma · condition mapped CURATED_BROADER · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03721068Phase 1 · recruiting Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01587300recruiting Neuroblastoma Biology Study · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02298348Phase 1 · active not recruiting Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02573896Phase 1 · active not recruiting Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02868268active not recruiting Neuroblastoma Precision Trial · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03478462Phase 1 · active not recruiting Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02780128Phase 1 · terminated Next Generation Personalized Neuroblastoma Therapy · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00026312Phase 3 · completed Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma · condition mapped CURATED_BROADER · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03581240available An Intermediate Expanded Use Trial of DFMO · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03794349Phase 2 · active not recruiting Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | High Risk Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02909777Phase 1 · completed Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06831552NA · recruiting Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07399821Phase 1/Phase 2 · recruiting An Imaging Study of Anti-GD2-800CW in Patients With Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04706910Phase 3 · recruiting 18F-DOPA II - PET Imaging Optimization · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05890781NA · recruiting Engineering Immune Organoids to Study Pediatric Cancer · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01625351Phase 1 · completed A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07375563Phase 3 · recruiting Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and Ganglioneuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01175356Phase 1 · completed Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Ganglioneuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01231906Phase 3 · completed Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Peripheral Primitive Neuroectodermal Tumor of Bone | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07334301Phase 1/Phase 2 · recruiting A Multi-Arm, Platform Trial For Relapsed Neuroblastoma · condition mapped CURATED_BROADER · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03057626active not recruiting Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma · condition mapped CURATED_BROADER · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00085930Phase 1 · completed Blood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell Receptors to Neuroblastoma Patients · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01757626Phase 1/Phase 2 · active not recruiting Combination Therapy of Antibody Hu3F8 With Granulocyte- Macrophage Colony Stimulating Factor (GM-CSF) in Patients With Relapsed/Refractory High-Risk Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05400603Phase 1 · recruiting Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06803875Phase 1/Phase 2 · recruiting Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma · condition mapped CURATED_BROADER · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01850888NA · completed MIBG for Refractory Neuroblastoma and Pheochromocytoma · condition mapped CURATED_BROADER · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04541082Phase 1 · recruiting Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03500991Phase 1 · active not recruiting HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03638167Phase 1 · completed EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02307630NA · active not recruiting PET Imaging of Solid Tumors Using 124I-Humanized 3F8: A Pilot Study · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06818916NA · recruiting Hetrombopag in Promoting Platelet Engraftment After Auto-HSCT in Children With Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05770037Phase 2/Phase 3 · recruiting DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06988475Phase 2/Phase 3 · recruiting DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04081701Phase 4 · recruiting 68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors. · condition mapped ALIAS · 673 trials mapped (177 active) | — | — | Olfactory Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03618381Phase 1 · active not recruiting EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00996710active not recruiting Genomic Structural Variation in Cancer Susceptibility · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02162732NA · completed Molecular-Guided Therapy for Childhood Cancer · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07223606no longer available Fecal Microbiota Transplant for Neuroblastoma in a Single Patient · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04385277Phase 2 · active not recruiting Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL) · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Ganglioneuroblastoma, Nodular | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02605421Phase 2 · recruiting Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02508038Phase 1 · recruiting Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00588068recruiting Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05429502Phase 1 · terminated Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03033303Phase 2 · completed A Study of the Effect of Hu3F8/GM-CSF Immunotherapy Plus Isotretinoin in Patients in First Remission of High-Risk Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05296564Phase 1/Phase 2 · recruiting Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers · condition mapped CURATED_BROADER · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02245997early Phase 1 · completed Local Control With Reduced-dose Radiotherapy for High-Risk Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07195500recruiting Clinical Application of Somatostatin Receptor and Norepinephrine Transporter Targeted Imaging for Diagnosis and Staging of Neuroblastoma and Pheochromocytoma/Paraganglioma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03294954Phase 1 · recruiting GD2 Specific CAR and Interleukin-15 Expressing Autologous NKT Cells to Treat Children With Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04023331Phase 1/Phase 2 · terminated 67Cu-SARTATE™ Peptide Receptor Radionuclide Therapy Administered to Pediatric Patients With High-Risk, Relapsed, Refractory Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03107988Phase 1 · completed NANT 2015-02: A Phase 1 Study of Lorlatinib (PF-06463922) · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06798532not yet recruiting Interest of Preoperative Arteriography to Identify the Adamkiewicz Artery Before Surgery for Basi-thoracic Neuroblastic Tumors · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastic Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07167329Phase 2 · recruiting Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL Trial · condition mapped ALIAS · 673 trials mapped (177 active) | — | — | Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07111117Phase 2 · not yet recruiting Comparison of 18F Labeled Analog of MIBG (18F-MFBG) PET/CT and 123I-MIBG SPECT in Pediatric Patients With Neuroblastoma. · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07141862recruiting Fertility Preservation in Children With Solid Tumors: Detection of Residual Disease by a Sensitive Method · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05135975Phase 2 · recruiting A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05012098Phase 2 · completed Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON). · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Olfactory Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06852807recruiting 18F-mFBG PET Imaging in the Evaluation of Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02650648Phase 1 · completed Humanized Anti-GD2 Antibody Hu3F8 and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07067346early Phase 1 · recruiting Safety & Efficacy of IR-101 in Relapsed/Refractory Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07090538early Phase 1 · not yet recruiting GSL Synthetase Inhibitor Plus GM-CSF and/ or Immune Checkpoint Inhibitor in Previously Treated High-Risk Neuroblastoma. · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06872489available Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05192980NA · recruiting SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07064746recruiting Clinical Application Study of [123I]Metaiodobenzylguanidine and Somatostatin Receptor-Targeted Imaging in the Diagnosis and Staging of Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07072143recruiting An International Study on Pediatric Patients With Rare Tumors. · condition mapped ALIAS · 673 trials mapped (177 active) | — | — | Olfactory Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04239092Phase 1 · terminated 9-ING-41 in Pediatric Patients With Refractory Malignancies. · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06485947Phase 1 · recruiting Study Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00703222Phase 1/Phase 2 · completed A Phase I/II Study Of Immunization With Lymphotactin And Interleukin 2 Gene Modified Neuroblastoma Tumor Cells · condition mapped ONTOLOGY_EXACT · 673 trials mapped (177 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |